KOSUNI KOREA
Korean News in English

Business

3235 articles

Student Uniform Collusion Case: A Firsthand Experience with the Victim Registration Site
Business

Student Uniform Collusion Case: A Firsthand Experience with the Victim Registration Site

This article details the ongoing issue of collusion among uniform manufacturers in South Korea, leading to inflated prices for parents. The Fair Trade Commission has imposed fines totaling 320 million won on 27 companies and is considering raising penalty thresholds.
Sep 27, 2026
Why Female Employees Leave: Causes and Real-World Examples
Business

Why Female Employees Leave: Causes and Real-World Examples

This article examines the reasons behind female employee attrition in South Korean workplaces, highlighting organizational issues like gender discrimination and lack of work-life balance support, with real case studies and solutions.
Sep 27, 2026
How Park Sol-mi and Song Hye-kyo's Friendship Boosted a Kimchi Brand's Success
Business

How Park Sol-mi and Song Hye-kyo's Friendship Boosted a Kimchi Brand's Success

The kimchi brand co-founded by actress Park Sol-mi gained massive popularity after Song Hye-kyo, her close friend, promoted it on social media. The brand achieved 45 billion won in sales by May 2025.
Sep 27, 2026
South Korea-Mexico Economic Cooperation: New Agreement Details and Expected Benefits
Business

South Korea-Mexico Economic Cooperation: New Agreement Details and Expected Benefits

South Korea and Mexico are advancing economic cooperation through a comprehensive economic agreement rather than reviving their existing Free Trade Agreement (FTA), focusing on oil, critical minerals, and advanced industries.
Sep 27, 2026
New York Stock Market Mixed Closing as Semiconductor Stocks Drive Nasdaq to Record High
Business

New York Stock Market Mixed Closing as Semiconductor Stocks Drive Nasdaq to Record High

The New York stock market closed mixed on September 22, 2026, with semiconductor stocks driving the Nasdaq to a record high despite rising U.S. Treasury yields.
Sep 27, 2026
Hanwha KAI Stake Acquisition Strategy: Analyzing Investor and Corporate Dynamics
Business

Hanwha KAI Stake Acquisition Strategy: Analyzing Investor and Corporate Dynamics

Hanwha Group has secured a 15.89% stake in Korea Aerospace Industries (KAI), positioning itself as the second-largest shareholder and signaling strategic moves to enhance synergies in aerospace, defense, and space sectors.
Sep 27, 2026
Why the World Is Watching the US-China Dispute Over International Waterway Toll Fees
Business

Why the World Is Watching the US-China Dispute Over International Waterway Toll Fees

The recent US-China summit saw leaders agree to jointly oppose toll fees on key international waterways, aiming to maintain open access for global energy transport through critical routes like the Strait of Hormuz.
Sep 27, 2026
Hanwha KAI Stake Acquisition Strategy: Securing External Investment Path
Business

Hanwha KAI Stake Acquisition Strategy: Securing External Investment Path

Hanwha Group is gradually increasing its stake in Korea Aerospace Industries (KAI) to build a defense industry value chain and realize a 'Korean Space X'. The company has expanded its ownership from 8% to 15.89% through multiple acquisitions.
Sep 27, 2026
Impact of Hormuz Strait Blockade on Gas Imports
Business

Impact of Hormuz Strait Blockade on Gas Imports

A detailed analysis of how a potential blockade of the Hormuz Strait could disrupt South Korea's energy supply chains, affecting industries and consumer prices.
Sep 27, 2026
Keytruda Biosimilar Development by Samsung Bioepis: Efficacy and Side Effect Comparison
Business

Keytruda Biosimilar Development by Samsung Bioepis: Efficacy and Side Effect Comparison

Samsung Bioepis is advancing its Keytruda biosimilar development with global clinical trials underway, targeting market leadership in the biosimilar sector by 2026 as patents expire.
Sep 27, 2026
Samsung Bioepis' Keytruda Biosimilar SB27 Shows Promising Cancer Treatment Results: Clinical Outcomes and Market Outlook
Business

Samsung Bioepis' Keytruda Biosimilar SB27 Shows Promising Cancer Treatment Results: Clinical Outcomes and Market Outlook

Samsung Bioepis has demonstrated that its biosimilar Keytruda product SB27 shows equivalent efficacy to the original drug in clinical trials, with regulatory approval application completed for a market poised for growth as Keytruda's patent expires.
Sep 27, 2026
SK Hynix Chongqing Plant's Technical Features and Production Methods
Business

SK Hynix Chongqing Plant's Technical Features and Production Methods

SK Hynix is considering selling its stake in the Chongqing NAND flash post-processing plant, though it has denied any confirmed plans. The company is also planning a domestic investment of 54 trillion won to strengthen its production capabilities.
Sep 27, 2026